We are live on ! Find out more
IMMP

Immutep

5 hedge funds and large institutions have $74K invested in Immutep in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

573% more capital invested

Capital invested by funds: $11K → $74K (+$63K)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more funds holding

Funds holding: 35 (+2)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$39K +$80.3K +10,295 New
Morgan Stanley
2
Morgan Stanley
New York
$20K +$40.5K +5,192 New
Deutsche Bank
3
Deutsche Bank
Germany
$10K +$22.6K +2,894 New
U
4
UBS
Switzerland
$5K +$7.17K +919 +236%
Citigroup
5
Citigroup
New York
-$6K -879 Closed
TRCT
6
Tower Research Capital (TRC)
New York
-$2K -219 Closed
Ameriprise
7
Ameriprise
Minnesota
+$47 +6 New

IMMP Hedge Fund Activity: Q3 2013 in Review

5 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q3 2013, worth a combined $74K — up 573% from $11K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IMMP positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $40.5K. The largest seller was Citigroup, exiting entirely with an estimated $6K sold.

  • 5 institutional investors held Immutep (IMMP) as of Q3 2013, up from 3 in Q2 2013.
  • Funds reported $74K of Immutep stock for Q3 2013, up 573% quarter-over-quarter.
  • 4 funds opened new Immutep positions in Q3 2013 and 2 closed out, a net change of +2 holders.
  • The largest Immutep buyer in Q3 2013 was Morgan Stanley, an estimated $40.5K added.
  • The largest Immutep seller in Q3 2013 was Citigroup, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2013.